Alere Inc. (ALR) Announces Completion of $425 Million Senior Subordinated Notes Offering and Early Results of Its Tender Offer and Consent Solicitation for Any and All of its 9% Senior Subordinated Notes due 2016
5/29/2013 9:56:58 AM
More...
|
Alere Inc. (ALR) to Attend Jefferies and Co. 2013 Global Healthcare Conference on June 4th
5/24/2013 6:14:24 AM
More...
|
Alere Inc. (ALR) to Attend Goldman, Sachs & Co. 34th Annual Global Healthcare Conference on June 13th
5/24/2013 6:11:00 AM
More...
|
Alere Inc. (ALR) Declares Cash Dividend on Its Series B Convertible Perpetual Preferred Stock
5/17/2013 9:15:55 AM
More...
|
Alere Inc. (ALR) Announces Pricing of Senior Subordinated Notes Offering
5/14/2013 9:14:56 AM
More...
|
Alere Inc. (ALR) Announces Offering of $425 Million of Senior Subordinated Notes
5/14/2013 8:41:23 AM
More...
|
Alere Inc. (ALR) Announces First Quarter 2013 Results
5/9/2013 6:59:59 AM
More...
|
Alere Inc. (ALR) Schedules Conference Call for 8:30 a.m. ET May 9, 2013 to Discuss First Quarter 2013 Results
5/2/2013 7:43:17 AM
More...
|
Alere Inc. (ALR) Release: Pilot Study Demonstrates Home BNP Testing is Feasible & Suggests Home Monitoring May Have Value in Guiding Therapy for High-Risk Patients
4/25/2013 9:22:13 AM
More...
|
Alere Inc. (ALR) to Launch "Test Target Treat™" Campaign at 9th Annual International Symposium on Antimicrobial Agents and Resistance
3/13/2013 9:54:32 AM
More...
|
|